 EVERSANA to commercialize and distribute Gimoti in the U.S. SOLANA BEACH, Calif. and CHICAGO, Jan. 23, 2020 GLOBE NEWSWIRE -- Evoke Pharma, Inc. EVOK, a specialty pharmaceutical company focused on treatments for gastrointestinal GI diseases, and EVERSANATM, an independent provider of global commercial services to the life science industry, today announced a collaboration to utilize EVERSANAs integrated suite of outsourced services to commercialize and distribute GimotiTM in the United States U.S.. Gimoti is Evokes nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis. 